Market revenue in 2023 | USD 66.6 million |
Market revenue in 2030 | USD 111.7 million |
Growth rate | 7.7% (CAGR from 2023 to 2030) |
Largest segment | Logistics & distribution |
Fastest growing segment | Logistics & distribution |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Logistics & distribution, Storage & retention, Packaging, labeling and blinding, Manufacturing, Comparator sourcing, Other services (solutions, ancillary supply) |
Key market players worldwide | Thermo Fisher Scientific Inc, Catalent Inc, PAREXEL, Almac Group, Piramal Pharma Solutions, DHL Group, FedEx Corp, UDG Healthcare, Marken, Walden Group, PCI Pharma Services |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial supply & logistics market will help companies and investors design strategic landscapes.
Logistics & distribution was the largest segment with a revenue share of 25.38% in 2023. Horizon Databook has segmented the South Korea clinical trial supply & logistics market based on logistics & distribution, storage & retention, packaging, labeling and blinding, manufacturing, comparator sourcing, other services (solutions, ancillary supply) covering the revenue growth of each sub-segment from 2018 to 2030.
South Korea clinical trial supply and logistics market has grown rapidly over the last 10 years. In this period, many of the major pharmaceutical players entered Seoul seeking access to the country’s broad patient pool.
Moreover, local South Korean pharmaceutical players started focusing on developing new drugs of their own, as the government is supporting the life sciences industry. The country has one of the most efficient clinical trial approval processes of 30 working days.
It has a research-intensive environment, advanced IT infrastructure with highly educated & motivated resources, and rapid expenditure on R&D. Sites in Korea have established track records in quality as well as efficiency in clinical trials.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea clinical trial supply & logistics market , including forecasts for subscribers. This country databook contains high-level insights into South Korea clinical trial supply & logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account